Login / Signup
David Valdés-Arias
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 6
Top Topics
Spinal Cord
Public Health
Phase Ii
Neuropathic Pain
Top Venues
Drugs
Ophthalmic epidemiology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Germán Mejía-Salgado
,
Carlos Cifuentes-González
,
Laura Zarate-Pinzón
,
Luisa Fernanda Peña-Pulgar
,
William Rojas-Carabali
,
David Valdés-Arias
,
Danna Lesley Cruz
,
Alejandra de-la-Torre
Colombian Ocular Diseases Epidemiology Study (CODES): Prevalence and Sociodemographic Characterization of Refractive Errors in Colombian Eye Care Consultations.
Ophthalmic epidemiology
(2024)
David Valdés-Arias
,
Elyana Vittoria Tessa Locatelli
,
Paula A Sepulveda-Beltran
,
Simran Mangwani-Mordani
,
Juan Carlos Navia
,
Anat Galor
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease.
Drugs
(2024)
David Valdés-Arias
,
Elyana Vittoria Tessa Locatelli
,
Paula A Sepulveda-Beltran
,
Simran Mangwani-Mordani
,
Juan Carlos Navia
,
Anat Galor
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease.
Drugs
84 (5) (2024)
David Valdés-Arias
,
Elyana Vittoria Tessa Locatelli
,
Paula A Sepulveda-Beltran
,
Simran Mangwani-Mordani
,
Juan Carlos Navia
,
Anat Galor
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease.
Drugs
84 (5) (2024)
David Valdés-Arias
,
Elyana Vittoria Tessa Locatelli
,
Paula A Sepulveda-Beltran
,
Simran Mangwani-Mordani
,
Juan Carlos Navia
,
Anat Galor
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease.
Drugs
84 (5) (2024)
David Valdés-Arias
,
Elyana Vittoria Tessa Locatelli
,
Paula A Sepulveda-Beltran
,
Simran Mangwani-Mordani
,
Juan Carlos Navia
,
Anat Galor
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease.
Drugs
84 (5) (2024)